These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1630172)

  • 1. [Course of human immunodeficiency virus infection and programs with adequate retention capacity in the control of acquired immunodeficiency syndrome and tuberculosis in parenteral drug addicts].
    Caylà JA; Jansà JM; Serrano J; Garrell E
    Med Clin (Barc); 1992 Apr; 98(16):636-7. PubMed ID: 1630172
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis, AIDS, and i.v. drug abuse.
    Lamb RJ; Yeh IT
    N J Med; 1990 May; 87(5):413-5. PubMed ID: 2352666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of drug abuse treatment programs in AIDS prevention and education programs for intravenous drug users: the New Jersey experience.
    Jackson JF; Rotkiewicz LG; Baxter RC
    NIDA Res Monogr; 1990; 93():167-86. PubMed ID: 2300140
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of human immunodeficiency virus type 1 and Mycobacterium tuberculosis infections in a prison population in the years 1989 to 1995].
    Pérez-Agudo F; Alonso Moreno FJ; Urbina Torija J
    Med Clin (Barc); 1998 Feb; 110(5):167-70. PubMed ID: 9547719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AIDS prevention in drug addicts: securing the provision of sterile syringes].
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):866. PubMed ID: 8372283
    [No Abstract]   [Full Text] [Related]  

  • 7. [4-year experience of the Lund model for HIV/AIDS prevention. Needle-exchange program as a bridge to continued care of drug addicts].
    Tunving K; Nyholm K
    Lakartidningen; 1991 May; 88(19):1797, 1799. PubMed ID: 2041431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Free interpretations of facts on the HIV epidemic among drug addicts].
    Tunving K
    Lakartidningen; 1991 Jul; 88(30-31):2505-6. PubMed ID: 1865715
    [No Abstract]   [Full Text] [Related]  

  • 9. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS infection rate falls among Brazil's injection drug users.
    AIDS Policy Law; 2002 Jun; 17(11):6. PubMed ID: 12083042
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infectious diseases in intravenous drug abuse patients].
    Leusden RP; Stark K
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):709-16. PubMed ID: 1529622
    [No Abstract]   [Full Text] [Related]  

  • 12. [AIDS and tuberculosis in the light of spreading drug abuse].
    Volkova KI; Kokosov AN
    Klin Med (Mosk); 1999; 77(2):7-12. PubMed ID: 10380453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug addiction, tuberculosis and infection with the human immunodeficiency virus].
    de Miguel J; Coiradas A; Castro A; Pedreira JD
    Rev Clin Esp; 1988 Mar; 182(4):242-3. PubMed ID: 3413321
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America--the Argentinean case.
    Rossi D; Goltzman P; Cymerman P; Touzé G; Weissenbacher M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S362-5. PubMed ID: 14648448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kaposi's sarcoma with primary pulmonary involvement in a parenteral drug addict with acquired immunodeficiency syndrome].
    Romeu J; Sirera G; Rincón R; Inaraja L; Ojanguren I; Tor J; Clotet B
    Med Clin (Barc); 1991 May; 96(18):696-9. PubMed ID: 2072777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic cost of strict syringe control.
    Rich JD; Dokson L; Dickinson BP
    Med Health R I; 1998 Jun; 81(6):207-8. PubMed ID: 9654898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurosyphilis and infection with the human immunodeficiency virus].
    Pascual Velasco F; Muñoz Calvo B
    Rev Clin Esp; 1990 Nov; 187(8):434. PubMed ID: 2091144
    [No Abstract]   [Full Text] [Related]  

  • 18. [AIDS and drug addiction: the time for methadone has come].
    Muga R; Egea JM
    Med Clin (Barc); 1994 May; 102(17):657-8. PubMed ID: 8065204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk of tuberculosis in parenteral drug addicts with human immunodeficiency virus seropositivity. A cohort study in detoxication communities].
    Solera J; López E; Serna E; Vergara L; Martínez-Alfaro E; Sáez L
    Med Clin (Barc); 1993 May; 100(19):725-9. PubMed ID: 8315960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyslipemia and HIV-1 infection in intravenous drug addicts].
    Muga R; Tor J; Rey-Joly C; Pardo A; Llobet P; Foz M
    Med Clin (Barc); 1993 Feb; 100(5):161-3. PubMed ID: 8450692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.